D

Doctolib

Online appointment booking and teleconsultation platform

EU Public Affairs Senior Consultant

Full-Time
No salary listed
Mid
Bachelor's
Paris, France
HybridUp to 2 remote days per week; regular travel to Brussels and Strasbourg is required.
Business & StrategyCorporate Strategy

About the job

Requirements
  • Have 4 to 5 years of experience in European public affairs, EU policy, European law, international relations or a related field.
  • Have previous experience in Brussels or Strasbourg within an EU institution, Permanent Representation, professional federation, consultancy or interest representation organisation.
  • Have a solid understanding of EU institutions and EU legislative and decision-making processes, and be comfortable navigating a complex multi-stakeholder environment.
  • Have strong analytical, synthesis and drafting skills, with hands-on experience preparing position papers, consultation responses or institutional meeting reports.
  • Be fluent in both French and English, written and spoken, at C1 level or above, with the ability to produce clear and concise content for varied audiences.
Responsibilities
  • Monitor EU legislative and regulatory developments across key policy areas, including the AI Act, EHDS, GDPR, NIS2, Data Act, cybersecurity and digital sovereignty, and produce timely, actionable analysis for internal stakeholders.
  • Support the preparation of Doctolib's positions, consultation responses and contributions to EU institutions and professional associations.
  • Organise and follow up on meetings with EU institutions, Permanent Representations and European stakeholders, ensuring proper documentation and follow-through.
  • Collaborate with internal teams, including Legal, Risk and Technology & Product, to foster alignment on EU regulatory topics and translate complex issues into clear, actionable insights.
  • Contribute to Doctolib's engagement with European federations and industry associations, helping maximise the value of Doctolib's participation and strengthen its visibility at the European level.
  • Coordinate with Public Affairs colleagues in Germany and Italy on cross-border regulatory priorities and shared engagement strategies.
Desired Qualifications
  • Have initial knowledge of European digital and health legislation, such as the AI Act, EHDS, GDPR, NIS2, Data Act, MDR/IVDR or European cybersecurity legislation.
  • Have previous experience in healthcare, digital, technology or another regulated sector, or a good understanding of how European federations and professional associations operate.
  • Have an academic qualification or experience in EU Law.
  • Speak an additional European language, particularly German.

About the company

Doctolib runs a digital healthcare platform that connects patients with healthcare professionals, mainly in France, Germany, and Italy. It provides online appointment booking, teleconsultation, and practice-management tools through subscription-based software for medical practices, hospitals, and individual clinicians. The platform helps patients find and book care quickly while giving providers a centralized system to manage schedules, patient communications, and administrative tasks. Unlike many options that focus on one feature, Doctolib combines patient access with practice management in a single solution, serving multiple types of healthcare clients across several European countries. The company’s goal is to make healthcare more efficient and easier to access by streamlining operations for providers and reducing barriers to care for patients, using a scalable subscription model to grow across markets.

Company Size

1,001-5,000

Company Stage

Late Stage VC

Total Funding

$810.9M

Headquarters

Levallois-Perret, France

Founded

2013

Get referred to Doctolib

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Doctolib announced a May 2026 Medicus acquisition and £100 million UK investment.
  • The Adyen partnership adds embedded payments, expanding monetization beyond subscriptions in France and Italy.
  • Doctolib’s July 2026 roadmap signals 2027 product launches and deeper AI-led workflow automation.

What critics are saying

  • France’s Autorité de la concurrence fined Doctolib €4.665 million on November 6, 2025.
  • That ruling targeted exclusivity and bundling, inviting follow-on complaints from Cegedim Santé and rivals.
  • If UK NHS procurement rejects Medicus integration, Doctolib’s £100 million expansion burns cash fast.

What makes Doctolib unique

  • Doctolib combines booking, teleconsultation, billing, and practice software across France, Germany, Italy, and Britain.
  • Its 2026 AI lab with CHU de Nantes targets clinician workflow automation.
  • The Medicus acquisition gives Doctolib NHS-native primary-care software and UK market entry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options
  • Phone/Internet Stipend
  • Wellness Program
  • Professional Development Budget
  • Flexible Work Hours
  • Health Insurance
  • Paid Vacation
  • Paid Sick Leave
  • Paid Holidays
  • Parental Leave
  • Mental Health Support
  • Meal Benefits

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Finanzen.net
Oct 13th, 2026
Nvidia stock in focus: AI group invests in doctors' platform Doctolib.

Nvidia stock in focus: AI group invests in doctors' platform Doctolib. Oct 13, 2026, 10:19 p.m. US chipmaker Nvidia is taking a minority stake in the French doctors' platform Doctolib. Doctolib CEO Stanislas Niox-Chateau announced this in Paris in the evening. "This investment will enable us to attract AI talent more quickly and drive our development forward," he stressed. It initially remained unclear how many shares Nvidia would acquire. With Nvidia's investment, Doctolib aims to further develop its own artificial intelligence-based solutions and models in Europe, the company announced. In Germany, Doctolib is known primarily for its online platform through which patients can book appointments with medical practices. Another core product is the AI telephone assistant, which medical practices can also use to organize appointments by phone. The company also offers solutions for administrative and accounting tasks in practices. Doctolib builds its own applications on existing language models. With Nvidia's investment, the company says it hopes to gain access to the US group's AI experts and support in training its own models. Nvidia chips: central engine of the AI boom Nvidia, in turn, is the central engine of the AI boom with its chip products for data centers. Above all, cloud heavyweights such as Amazon, Google, Microsoft, and Meta are investing hundreds of billions of dollars in expanding AI data centers. Most recently, Nvidia strengthened its position with a multibillion-dollar acquisition of the AI platform Hugging Face. The group often uses the billions in profits from its chip sales for investments - usually in companies that are customers of the group. Doctolib emphasized that all of the company's health data were stored on servers within the European Union and the United Kingdom and remained there. "This also applies to the AI models," it said. The Nvidia stock ultimately traded 0.27 percent higher at $229.15 in Nasdaq trading. /maa/DP/men Berlin (dpa-AFX) Selected leveraged products on Amazon. With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired leverage and we will show you suitable open-end products on Amazon. | Name | Leverage | Knock-out | Issuer | | Mini Future Long on Amazon | 5.00 | 218.10 | Morgan Stanley | | Turbo Long on Amazon | 4.98 | 207.42 | Morgan Stanley | | Turbo Long on Amazon | 4.98 | 207.50 | Morgan Stanley | | Turbo Long on Amazon | 4.95 | 207.64 | Morgan Stanley | | Mini Future Long on Amazon | 4.95 | 217.58 | Morgan Stanley | You can obtain the base prospectus as well as the final terms and the key information documents here: MN756X, MR2GNC, MR85QR, MN7NQ3, MN756W. Please also note the further information** on this advertisement. Risk warning: On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suitable for long-term investment strategies.

KFGO
Oct 13th, 2026
Nvidia to take minority stake in French healthcare booking platform Doctolib

Nvidia will buy a minority stake in French healthcare booking platform Doctolib. Doctolib did not specify the size or value of the stake. It said Nvidia's presence would help it develop artificial intelligence tools.

CF News
May 7th, 2026
TECH | Doctolib gets a foothold in the United Kingdom.

TECH | Doctolib gets a foothold in the United Kingdom. Published on May 7, 2026 at 4:02 PM, updated on May 7, 2026 at 4:03 PM | 589 words The unicorn Doctolib takes a foothold across the Channel with the acquisition... After the acquisition of Italian Dottori.it in 2021, Dutch Siilo in 2023 and German Aaron.ai in 2024, the French unicorn Doctolib is setting up in the United Kingdom with the acquisition of Medicus (...) To access this article, the entire site and our databases, discover our subscription plans. BioTech, FinTech, MedTech... Follow all the deals and movements of TECH on social networks.

Sifted
May 5th, 2026
Health unicorn Doctolib plots £100m UK expansion, acquires London-based Medicus

The French scaleup says plans to hire 150 people and open a R&D centre in London

Tech.eu
Apr 17th, 2026
Doctolib, AP-HP and Roche launch healthtech startup programme at STATION F

Doctolib, AP-HP and Roche have launched Care Forward, a support programme for European healthtech startups at STATION F in Paris. The initiative aims to bridge the gap between healthcare innovation and clinical deployment by providing startups with direct access to hospital environments, regulatory expertise and AI support. The programme targets startups developing technologies across the care pathway, including digital solutions, AI, connected devices and healthcare services. Doctolib will offer technology integration and European deployment strategies, whilst AP-HP provides access to clinical environments across Europe's largest university hospital system with 38 hospitals. Roche will assist with regulatory navigation and health economic validation. Participating startups will also gain access to specialised investors and exclusive industry events. Applications are open until 15 May.